ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)
European Urology Open Science
◽
10.1016/s2666-1683(20)33842-8
◽
2020
◽
Vol 19
◽
pp. e1844-e1845
Author(s):
L.C.V. Thomsen
◽
A. Honoré
◽
B. Almås
◽
L.A.R. Reisæter
◽
K. Førde
◽
...
Keyword(s):
Prostate Cancer
◽
Dendritic Cell
◽
Phase I
◽
Phase I Trial
◽
Checkpoint Inhibition
◽
Castration Resistant Prostate Cancer
◽
Safety And Efficacy
◽
Castration Resistant
Download Full-text
Related Documents
Cited By
References
Abstract CT066: Dendritic cell based cryoimmunotherapy associates with clinical variables and changes in T-cell receptor expression in a prospective phase I trial of metastatic castration resistant prostate cancer
10.1158/1538-7445.am2018-ct066
◽
2018
◽
Author(s):
Liv Cecilie V. Thomsen
◽
Alfred Honorè
◽
Bjarte Almås
◽
Lars A. Reisæter
◽
Jannicke Frugård
◽
...
Keyword(s):
Prostate Cancer
◽
Dendritic Cell
◽
Phase I
◽
T Cell Receptor
◽
Phase I Trial
◽
Cell Receptor
◽
Receptor Expression
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Prospective Phase
Download Full-text
Dendritic cell (DC) based cryoimmunotherapy (CryoIT) in a prospective phase I trial of metastatic castration resistant prostate cancer (mCRPC): Interim analysis.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.e17014
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. e17014-e17014
Author(s):
Alfred Honoré
◽
Liv Cecilie Vestrheim Thomsen
◽
Bjarte Almås
◽
Lars Anders Reisæter
◽
Jannicke Frugård
◽
...
Keyword(s):
Prostate Cancer
◽
Dendritic Cell
◽
Phase I
◽
Interim Analysis
◽
Phase I Trial
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Prospective Phase
Download Full-text
Abstract 748: Phase I trial of fractionated-dose177Lutetium radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) in patients with metastatic castration-resistant prostate cancer (metCRPC)
10.1158/1538-7445.am2012-748
◽
2012
◽
Cited By ~ 1
Author(s):
Scott T. Tagawa
◽
Shankar Vallabhajosula
◽
Naveed H. Akhtar
◽
Joseph Osborne
◽
Himisha Beltran
◽
...
Keyword(s):
Prostate Cancer
◽
Monoclonal Antibody
◽
Phase I
◽
Phase I Trial
◽
Prostate Specific Membrane Antigen
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
◽
Specific Membrane
Download Full-text
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression
Cancer Immunology Immunotherapy
◽
10.1007/s00262-015-1660-1
◽
2015
◽
Vol 64
(4)
◽
pp. 493-505
◽
Cited By ~ 11
Author(s):
Masanori Noguchi
◽
Gaku Arai
◽
Kazumasa Matsumoto
◽
Seiji Naito
◽
Fukuko Moriya
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Cancer Vaccine
◽
Phase I Trial
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Open-label, phase I, dose escalation study to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E (GEN0101) in castration-resistant prostate cancer patients
European Urology Supplements
◽
10.1016/s1569-9056(19)30876-0
◽
2019
◽
Vol 18
(1)
◽
pp. e1220
Author(s):
K. Fujita
◽
Y. Nakai
◽
D. Kato
◽
A. Kawashima
◽
T. Ujike
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Cancer Patients
◽
Dose Escalation
◽
Castration Resistant Prostate Cancer
◽
Open Label
◽
Dose Escalation Study
◽
Safety And Efficacy
◽
Castration Resistant
◽
Open Label Phase
Download Full-text
PD32-04 PHASE I/II CLINICAL TRIAL TO ASSESS SAFETY AND EFFICACY OF INTRATUMORAL AND SUBCUTANEOUS INJECTION OF HVJ-E TO CASTRATION RESISTANT PROSTATE CANCER PATIENTS
The Journal of Urology
◽
10.1016/j.juro.2016.02.680
◽
2016
◽
Vol 195
(4S)
◽
Author(s):
Kazutoshi Fujita
◽
Yasutomo Nakai
◽
Koji Hatano
◽
Norihiko Kawamura
◽
Atsunari Kawashima
◽
...
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Phase I
◽
Cancer Patients
◽
Subcutaneous Injection
◽
Castration Resistant Prostate Cancer
◽
Safety And Efficacy
◽
Castration Resistant
Download Full-text
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
Oncotarget
◽
10.18632/oncotarget.4145
◽
2015
◽
Vol 6
(20)
◽
pp. 18192-18205
◽
Cited By ~ 62
Author(s):
Michal Podrazil
◽
Rudolf Horvath
◽
Etienne Becht
◽
Daniela Rozkova
◽
Pavla Bilkova
◽
...
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Dendritic Cell
◽
Phase I
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Abstract CT097: Phase I trial of apalutamide plus abiraterone acetate, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC)
10.1158/1538-7445.am2019-ct097
◽
2019
◽
Author(s):
Ana Molina
◽
Paul Christos
◽
Amy Hackett
◽
Luke Nordquist
◽
Edward Gelmann
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Phase I Trial
◽
Abiraterone Acetate
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Abstract CT097: Phase I trial of apalutamide plus abiraterone acetate, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC)
10.1158/1538-7445.sabcs18-ct097
◽
2019
◽
Author(s):
Ana Molina
◽
Paul Christos
◽
Amy Hackett
◽
Luke Nordquist
◽
Edward Gelmann
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Phase I Trial
◽
Abiraterone Acetate
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
A phase I trial of cabazitaxel ± rhenium-188-HEDP in patients with metastatic castration resistant prostate cancer who progressed on or after a docetaxel containing treatment.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.e16508
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. e16508-e16508
◽
Cited By ~ 1
Author(s):
Esther W. Bouman-Wammes
◽
Joyce M. van Dodewaard-de Jong
◽
Haiko Bloemendal
◽
John M. H. de Klerk
◽
Henk M.W. Verheul
◽
...
Keyword(s):
Prostate Cancer
◽
Phase I
◽
Phase I Trial
◽
Castration Resistant Prostate Cancer
◽
Castration Resistant
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close